Telomir Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Telomir Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TELO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001971532
Board of directors
-
Bradley Kroenig · DirectorSince 2024
-
Christopher C. Chapman Jr. · Director · CEO & ChairmanSince 2024
-
Christos Nicholoudis · Director · General CounselSince 2024
-
Craig Eagle · DirectorSince 2024
-
Edward Clouston MacPherson · DirectorSince 2024
-
Erez Aminov · Director · CEO and ChairmanSince 2024
-
Giudice Matthew Paul Del · DirectorSince 2024
-
Hugh McColl III · DirectorSince 2024
-
Matthew Pratt Whalen · DirectorSince 2024
-
Michael Allen Jerman · DirectorSince 2024
-
Talhia Tuck · DirectorSince 2024
Chief executives
Erez Aminov
· CEO & Chairman
Since August 2024
Christopher C. Chapman Jr.
· CEO & Chairman
2024 – 2024
· Former
Board connections
11 of this board's directors also sit on 5 other boards.
- via Bradley Kroenig, Christopher C. Chapman Jr., Christos Nicholoudis, Edward Clouston MacPherson, Erez Aminov, Giudice Matthew Paul Del, Hugh McColl III, Matthew Pratt Whalen, Michael Allen Jerman and Talhia Tuck
- via Christopher C. Chapman Jr. and Craig Eagle
- via Michael Allen Jerman
- via Craig Eagle
- via Hugh McColl III
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 22, 2026 | Erez Aminov Director, Officer (CEO and Chairman) | Other | +7,319,710 | $1.37 | $10,028,003 |
| Aug 19, 2024 | Erez Aminov Director, Officer (CEO and Chairman) | Open-market sale | −200 | $6.01 | $1,202 |
| Aug 19, 2024 | Erez Aminov Director, Officer (CEO and Chairman) | Open-market sale | −200 | $6.20 | $1,240 |
| Feb 13, 2024 | McNulty Brian Patrick 10% owner | Open-market purchase | +49,000 | $7.00 | $343,000 |
| Feb 13, 2024 | McNulty Brian Patrick 10% owner | Open-market purchase | +40,000 | $7.00 | $280,000 |
| Feb 13, 2024 | McNulty Brian Patrick 10% owner | Open-market purchase | +49,000 | $7.00 | $343,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.